Empagliflozin and metformin synergy in proximal tubular epithelial cells: does the combination alleviates hyperglycaemia-induced metabolic stress?

Warning

This publication doesn't include Faculty of Education. It includes Faculty of Medicine. Official publication website can be found on muni.cz.

Authors	GALUŠKA David PÁCAL Lukáš CHALÁSOVÁ Katarína KAŇKOVÁ Kateřina
Year of publication	2023
Type	Conference abstract
MU Faculty or unit	Faculty of Medicine
Citation
Description	Metformin remains the drug of first choice in type 2 diabetes mellitus (T2DM) worldwide since its beneficial metabolic effects are known for a long time.
Related projects:	Národní institut pro léčbu metabolických a kardiovaskulárních onemocnění